跳至主要内容
临床试验/NL-OMON53341
NL-OMON53341尚未招募不适用

MUSCLE study - Mitochondrial dysfUnction: a key player in doxorubicin-induced Skeletal and Cardiac muscLE damage? - MUSCLE

niversitair Medisch Centrum Utrecht0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 64(—)

入选标准

  • Age >= 18 years
  • Patients with large B-cell lymphoma or T-cell lymphoma scheduled for 6
  • full-dose cycles of 1st line immunochemotherapy with cyclophosphamide,
  • doxorubicin, vincristine and prednisone with or without rituximab ((reversed)
  • (R-)CHOP).
  • WHO-performance score 0-2.
  • Patients with sufficient Dutch writing and reading skills.
  • Written informed consent

排除标准

  • Contra-indications for 7T MR scanning
  • Any circumstances that would impede adherence to study requirements or
  • ability to give informed consent.
  • Medical disorders affecting mitochondrial function; e.g., spinal muscular
  • (Other) relevant medical disorders; e.g., comorbidities affecting exercise
  • Being under examination for non-diagnosed disease at the time of
  • investigation.

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验